NCT04464369View on ClinicalTrials.gov

Functional Dyspepsia: Validation of the Leuven Postprandial Distress Scale (LPDS) in a Placebo-controlled Trial

PHASE4CompletedINTERVENTIONAL

Enrollment

105

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions

Functional Dyspepsia

Interventions

DRUG

itopride

itopride is a gastroprokinetic drug that has previously been evaluated in the treatment of functional dyspepsia and which is available in a number of countries worldwide

DRUG

Placebo

placebo pills matching the look and weight of the itopride tablets

Trial Locations (1)

3000

University Hospitals Leuven, Leuven

All Listed Sponsors

lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT04464369 - Functional Dyspepsia: Validation of the Leuven Postprandial Distress Scale (LPDS) in a Placebo-controlled Trial | Biotech Hunter | Biotech Hunter